NCT06937892 - Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Generalized Anxiety Disorder (GAD)Social Anxiety Disorder (SAD)Posttraumatic Stress Disorder (PTSD)

Interventions

BEHAVIORAL

Transdiagnostic metacognitive therapy

A single, generic treatment protocol focusing on metacognitions.

BEHAVIORAL

Disorder-specific cognitive-behavioral therapy

Disorder-specific treatment protocols focusing on cognitions and/or behaviors.

Trial Locations (1)

RECRUITING

Stockholm North Psychiatry Clinic, Stockholm

All Listed Sponsors

collaborator

Karolinska Institutet

OTHER

collaborator

Region Stockholm

OTHER_GOV

lead

Benjamin Bohman

OTHER